Results 21 to 30 of about 3,390 (191)

Vasoplegia after cardiac surgery

, 2020
A case of severe refractory hypotension following a cardiac transplant is presented. In the hours after surgery, vasoplegia was diagnosed in the intensive care unit after exclusion of common causes of hypotension after cardiac surgery. Vasoplegia after cardiac surgery is a condition characterised by severe systemic hypotension, low systemic vascular ...
Duivenvoorden, M. M., Hermens, J. A.
openaire   +2 more sources

Role of Non-catecholamines Vasopressors in the Management of Vasoplegic Syndrome after Cardiopulmonary Bypass: A Scoping Review [PDF]

Annals of Cardiac Anaesthesia
Vasoplegic syndrome is a life-threatening condition characterized by uncontrolled peripheral vasodilation, leading to profound arterial hypotension. Treatments include catecholamines, vasopressin, methylene blue (MB), hydroxocobalamin, angiotensin II ...
Amarjeet Kumar, Athira Jayan, Poonam Kumari, Kunal Singh, Aakanksha Hiremath   +4 more
doaj   +2 more sources

Vasoplegia Following Complex Spine Surgery: Incidence and Risk

Global Spine Journal, 2022
Study design Retrospective cohort study Objectives Vasoplegia is a life-threatening form of distributive or vasodilatory shock that is characterized by reduced systemic vascular resistance with resultant hypotension and normal to elevated cardiac output ...
Basem Ishak MD, Juan N. Pulido MD, Alexander von Glinski MD, PhD, Darius Ansari BS, Rod J. Oskouian MD, Jens R. Chapman MD   +5 more
doaj   +3 more sources

Early Vasoplegia and Endothelial Protection in Sepsis: A Physiology-Guided Framework for Timely Albumin and Norepinephrine Therapy

International Journal of Translational Medicine
Background/Objective: Early hemodynamic instability in sepsis arises from endothelial dysfunction and vasoplegia before capillary leakage and organ failure occur.
Christian J. Wiedermann, Arian Zaboli, Gianni Turcato   +2 more
doaj   +2 more sources

Hydroxocobalamin for the treatment of vasoplegia after lung transplantation: A case series [PDF]

JHLT Open
Background: The use of hydroxocobalamin following lung transplantation has not been previously reported. We present a series of 3 cases where hydroxocobalamin was used to treat postoperative vasoplegia.
Anh Nguyen, MD, PhD, Rima Bouajram, PharmD, Marek Brzezinski, MD, Sahand Hassanipour, David Gordon, Binh Trinh, MD, Tobias Deuse, MD, Aida Venado, MD, Steve Hays, MD, Jonathan Singer, MD, Jasleen Kukreja, MD, MPH   +10 more
doaj   +2 more sources

The Durability of Intravenous Hydroxocobalamin in Vasoplegia

Cureus, 2023
Objectives Refractory distributive shock (vasoplegia) has been treated with intravenous (IV) hydroxocobalamin (B12), but its use is poorly characterized. The objective of this study was to quantify the duration of hemodynamic improvement after B12 administration. Materials and methods This was a retrospective chart review of adult patients who received
Blaha, Madeline, Blais, Meghan, Olson, Logan   +2 more
openaire   +2 more sources

Exploring Horizons in the Treatment of Vasoplegia in Shock Syndromes

The Eurasian Journal of Medicine, 2023
Vasoplegic endothelial dysfunction stands out as one of the most prominent shock syndromes in the intensive care unit, and despite continual therapeutic advances, it is still associated with poor prognosis in critical cases. This scenario is compatible with a significant inflammatory disturbance, with a propensity for increased vascular permeability ...
Ricardo Oliveira dos Santos Soares, Paulo Roberto Barbosa Evora   +1 more
openaire   +3 more sources

Vasoplegia after heart failure surgery [PDF]

, 2022
Vasoplegia is a common complication after heart failure surgery, although the incidence differs for each surgical procedure type. It is associated with poor early and late survival rates.
Vessem, M.E. van
core  

The use of angiotensin II for the treatment of post-cardiopulmonary bypass vasoplegia [PDF]

, 2020
Purpose Vasoplegia is a common complication after cardiac surgery and is related to the use of cardiopulmonary bypass (CPB). Despite its association with increased morbidity and mortality, no consensus exists in terms of its treatment.
Palmen, M., Papazisi, O., Danser, A.H.J., Danser, A. H. Jan, Palmen, Meindert, Papazisi, Olga, Meindert Palmen, A. H. Jan Danser, Olga Papazisi   +8 more
core   +3 more sources

Angiotensin-II for vasoplegia following cardiac surgery

Perfusion, 2023
Introduction The objective of this study was to describe the implementation and outcomes of a protocol outlining angiotensin-II utilization for vasoplegia following cardiac surgery. Methods This was a retrospective chart review at a ...
Andrew J Johnson, William Tidwell, Andrew McRae, C Patrick Henson, Antonio Hernandez   +4 more
openaire   +2 more sources